<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="issd" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">issd</book-part-id>
      <title-group>
        <title>Free Sialic Acid Storage Disorders</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Adams</surname>
            <given-names>David</given-names>
          </name>
          <xref ref-type="aff" rid="issd.AFF1"/>
          <degrees>MD, PhD</degrees>
          <email>dadams1@mail.nih.gov</email>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Gahl</surname>
            <given-names>William A</given-names>
          </name>
          <xref ref-type="aff" rid="issd.AFF2"/>
          <degrees>MD, PhD</degrees>
          <email>bgahl@helix.nih.gov</email>
        </contrib>
      </contrib-group>
      <aff id="issd.AFF1">National Human Genome Research Institute<break/>National Institutes of Health<break/>Bethesda, Maryland</aff>
      <aff id="issd.AFF2">Clinical Director, National Human Genome Research Institute<break/>National Institutes of Health<break/>Bethesda, Maryland</aff>
      <pub-history>
        <date iso-8601-date="2003-06-13" date-type="created">
          <day>13</day>
          <month>06</month>
          <year>2003</year>
        </date>
        <date iso-8601-date="2013-06-06" date-type="updated">
          <day>06</day>
          <month>06</month>
          <year>2013</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="focal-dh" document-type="chapter">Focal Dermal Hypoplasia</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="friedreich" document-type="chapter">Friedreich Ataxia</related-object>
      <abstract id="issd.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>The allelic disorders of free sialic acid metabolism &#x02014; Salla disease, intermediate severe Salla disease, and infantile free sialic acid storage disease (ISSD) &#x02014; are neurodegenerative disorders resulting from increased lysosomal storage of free sialic acid. The mildest phenotype is Salla disease, which is characterized by normal appearance and neurologic findings at birth followed by slowly progressive neurologic deterioration resulting in mild to moderate psychomotor retardation, spasticity, athetosis, and epileptic seizures. The most severe phenotype is ISSD, characterized by severe developmental delay, coarse facial features, hepatosplenomegaly, and cardiomegaly; death usually occurs in early childhood.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>Free sialic acid storage disorders result from defective free sialic acid transport out of lysosomes as a consequence of mutations in <italic toggle="yes">SLC17A5</italic>, encoding the lysosomal transport protein sialin. The diagnosis of a free sialic acid storage disorder is suggested by significantly elevated free (i.e., unconjugated) sialic acid (referred to as N-acetylneuraminic acid, a negatively charged sugar) in urine and/or cerebrospinal fluid using the fluorimetric thiobarbituric acid assay, thin-layer chromatography, or mass spectrometry. The diagnosis is established either by demonstrating lysosomal (rather than cytoplasmic) localization of elevated free sialic acid or by identifying disease-causing mutations in <italic toggle="yes">SLC17A5</italic>.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations</italic>: Management is symptomatic and supportive: rehabilitation to optimize mobility and communication; provision of adequate nutrition; standard treatment of seizures. </p>
          <p><italic toggle="yes">Surveillance</italic>: Regular evaluation by a rehabilitation specialist to identify potentially helpful interventions.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>The free sialic acid storage disorders are inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Prenatal testing for pregnancies at increased risk is possible by measuring free sialic acid either in chorionic villus biopsy specimens (obtained by chorionic villus sampling at ~10-12 weeks' gestation) or in amniocytes (obtained by amniocentesis usually performed at ~15-18 weeks' gestation). Carrier testing for relatives at increased risk and prenatal testing for pregnancies at increased risk is an option if both disease-causing mutations have been identified in a family.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="issd.GeneReview_Scope">
        <title><italic toggle="yes">GeneReview</italic> Scope</title>
        <table-wrap id="issd.T.nc_free_sialic_acid_storage_disor" position="anchor" orientation="portrait">
          <table>
            <tbody>
              <tr>
                <th id="hd_b_issd.T.nc_free_sialic_acid_storage_disor_1_1_1_1" align="left" valign="top" rowspan="1" colspan="1">Free Sialic Acid Storage Disorders: Included Disorders</th>
              </tr>
              <tr>
                <td headers="hd_b_issd.T.nc_free_sialic_acid_storage_disor_1_1_1_1" align="left" valign="top" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>Salla disease</p>
                    </list-item>
                    <list-item>
                      <p>Infantile free sialic acid storage disease </p>
                    </list-item>
                  </list>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="issd.TF.1">
              <p>For synonyms and outdated names see <xref ref-type="sec" rid="issd.Nomenclature">Nomenclature</xref>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="issd.Diagnosis">
        <title>Diagnosis</title>
        <sec id="issd.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>There are no consensus clinical diagnostic criteria for Salla disease. The diagnosis of Salla disease is suspected in individuals who manifest truncal ataxia and hypotonia at age approximately one year, developmental delays and growth retardation in early childhood, and severe cognitive and motor impairment or intellectual disability in adulthood. The association of intellectual disability, spasticity, ataxia, myelination defects, and facial coarsening in adulthood is suggestive of Salla disease.</p>
          <p>The diagnosis of infantile free sialic acid storage disease (ISSD) is suspected in individuals with early multisystemic involvement including: hydrops fetalis, hepatosplenomegaly, failure to thrive, increasingly coarse facial features, neurologic deterioration typical of a lysosomal storage disease, dysostosis, and early death [<xref ref-type="bibr" rid="issd.REF.helipwooley.2007.1">Helip-Wooley et al 2007</xref>].</p>
        </sec>
        <sec id="issd.Testing">
          <title>Testing</title>
          <p>
            <bold>Affected individuals</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Free sialic acid.</bold> Sialic acids are a family of negatively charged sugars, one of which, N-acetylneuraminic acid, is elevated in lysosomes in free sialic acid storage disorders:</p>
              <list list-type="bullet">
                <list-item>
                  <p><bold>Urinary excretion of free sialic acid,</bold> measured by the fluorimetric thiobarbituric acid assay, thin-layer chromatography or mass spectrometry, is elevated about tenfold in individuals with Salla disease and about 100-fold in individuals with ISSD. HPLC/tandem mass spectrometry is also able to detect free sialic acid in urine [<xref ref-type="bibr" rid="issd.REF.valianpour.2004.403">Valianpour et al 2004</xref>].Note: (1) In the thiobarbituric acid assay, interfering substances may lower the measurement and chromophores may contribute to absorbance, creating a false measurement. (2) In thin-layer chromatography, an elevation of free sialic acid may be overlooked. </p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Cultured fibroblasts</bold> from individuals with Salla disease and individuals with ISSD show increased concentration of free sialic acid [<xref ref-type="bibr" rid="issd.REF.renlund.1986.759">Renlund et al 1986</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Lysosomal localization of free sialic acid,</bold> suspected by electron microscopy of biopsy material (e.g., skin or liver), confirms the diagnosis of a free sialic acid storage disorder. Subcellular fractionation studies can demonstrate the lysosomal localization of the elevated free sialic acid.</p>
            </list-item>
          </list>
          <p><bold>Carriers.</bold> Biochemically based carrier testing is not feasible.</p>
          <sec id="issd.Molecular_Genetic_Testing">
            <title>Molecular Genetic Testing</title>
            <p><bold>Gene.</bold>
<italic toggle="yes">SLC17A5</italic> is the only gene in which mutations are known to cause Salla disease and ISSD.</p>
            <p>
              <bold>Clinical testing</bold>
            </p>
            <table-wrap id="issd.T.summary_of_molecular_genetic_test" position="anchor" orientation="portrait">
              <label>Table 1.</label>
              <caption>
                <p>Summary of Molecular Genetic Testing Used in Free Sialic Acid Storage Disorders</p>
              </caption>
              <table>
                <tbody>
                  <tr>
                    <th id="hd_b_issd.T.summary_of_molecular_genetic_test_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_b_issd.T.summary_of_molecular_genetic_test_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Test Method</th>
                    <th id="hd_b_issd.T.summary_of_molecular_genetic_test_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Mutations Detected&#x000a0;<sup>2</sup></th>
                    <th id="hd_b_issd.T.summary_of_molecular_genetic_test_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Mutation Detection Frequency by Test Method&#x000a0;<sup>3</sup></th>
                  </tr>
                  <tr>
                    <td headers="hd_b_issd.T.summary_of_molecular_genetic_test_1_1_1_1" align="left" valign="middle" rowspan="3" colspan="1">
                      <italic toggle="yes">SLC17A5</italic>
                    </td>
                    <td headers="hd_b_issd.T.summary_of_molecular_genetic_test_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Sequence analysis</td>
                    <td headers="hd_b_issd.T.summary_of_molecular_genetic_test_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">S</italic>equence variants&#x000a0;<sup>4</sup></td>
                    <td headers="hd_b_issd.T.summary_of_molecular_genetic_test_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Unknown</td>
                  </tr>
                  <tr>
                    <td headers="hd_b_issd.T.summary_of_molecular_genetic_test_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Targeted mutation analysis / mutation scanning of select exons&#x000a0;<sup>5</sup></td>
                    <td headers="hd_b_issd.T.summary_of_molecular_genetic_test_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1"><xref ref-type="table" rid="issd.T.slc17a5_allelic_variants_discusse">p.Arg39Cys</xref>&#x000a0;<sup>6</sup></td>
                    <td headers="hd_b_issd.T.summary_of_molecular_genetic_test_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Homozygous <xref ref-type="table" rid="issd.T.slc17a5_allelic_variants_discusse">p.Arg39Cys</xref> in individuals of Finnish origin (91%)&#x000a0;<sup>7</sup>
</td>
                  </tr>
                  <tr>
                    <td headers="hd_b_issd.T.summary_of_molecular_genetic_test_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Deletion/duplication analysis&#x000a0;<sup>8</sup></td>
                    <td headers="hd_b_issd.T.summary_of_molecular_genetic_test_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Exonic or whole gene deletions&#x000a0;<sup>8</sup></td>
                    <td headers="hd_b_issd.T.summary_of_molecular_genetic_test_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Unknown</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="issd.TF.2">
                  <label>1.</label>
                  <p>See <related-object source-id="gene" document-id="issd" object-id="issd.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
                </fn>
                <fn id="issd.TF.2.1">
                  <label>2.</label>
                  <p>See <xref ref-type="sec" rid="issd.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants. </p>
                </fn>
                <fn id="issd.TF.2.2">
                  <label>3.</label>
                  <p>The ability of the test method used to detect a mutation that is present in the indicated gene</p>
                </fn>
                <fn id="issd.TF.2.3">
                  <label>4.</label>
                  <p>Examples of mutations detected by sequence analysis may include small intragenic deletions/insertions and missense, nonsense, and splice site mutations; typically, exonic or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="issd.TF.2.4">
                  <label>5.</label>
                  <p>Mutation scanning of exon 2 may be used to detect the <xref ref-type="table" rid="issd.T.slc17a5_allelic_variants_discusse">p.Arg39Cys</xref> mutation.</p>
                </fn>
                <fn id="issd.TF.2.5">
                  <label>6.</label>
                  <p>The prevalence of <xref ref-type="table" rid="issd.T.slc17a5_allelic_variants_discusse">p.Arg39Cys</xref> is high in the founder region of northeastern Finland (see <xref ref-type="sec" rid="issd.Prevalence">Prevalence</xref>).</p>
                </fn>
                <fn id="issd.TF.2.6">
                  <label>7.</label>
                  <p>Finnish individuals with Salla disease [<xref ref-type="bibr" rid="issd.REF.aula.2000.832">Aula et al 2000</xref>]</p>
                </fn>
                <fn id="issd.TF.2.7">
                  <label>8.</label>
                  <p>Testing that identifies deletions/duplications not readily detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA; included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment. </p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
        </sec>
        <sec id="issd.Testing_Strategy">
          <title>Testing Strategy</title>
          <p><bold>To confirm/establish the diagnosis in a proband.</bold> Strong evidence for a sialic acid storage disorder (in order of the frequency of use in a clinical setting):</p>
          <list list-type="order">
            <list-item>
              <label>1</label>
              <p>Urinary excretion of sialic acid on the order of 100-fold normal</p>
            </list-item>
            <list-item>
              <label>2</label>
              <p>Sequence analysis of <italic toggle="yes">SLC17A5</italic> that reveals biallelic, well-described pathogenic mutations</p>
            </list-item>
            <list-item>
              <label>3</label>
              <p>Elevated fibroblast concentration of free sialic acid</p>
            </list-item>
            <list-item>
              <label>4</label>
              <p>Cell biologic studies showing localization of sialic acid to lysosomes </p>
            </list-item>
          </list>
          <p>Supportive evidence for a sialic acid storage disorder:</p>
          <list list-type="order">
            <list-item>
              <label>1</label>
              <p>Characteristic physical findings</p>
            </list-item>
            <list-item>
              <label>2</label>
              <p>Hypomelination evident on brain MRI</p>
            </list-item>
            <list-item>
              <label>3</label>
              <p>Urinary excretion of sialic acid on the order of tenfold normal </p>
            </list-item>
            <list-item>
              <label>4</label>
              <p>Elevated CSF sialic acid with or without elevated urinary excretion of sialic acid</p>
            </list-item>
            <list-item>
              <label>5</label>
              <p>Pathogenic-appearing but novel biallelic <italic toggle="yes">SLC17A5</italic> mutations detected by sequence analysis</p>
            </list-item>
          </list>
          <p><bold>Carrier testing of at-risk relatives</bold> requires prior identification of the disease-causing mutations in the family. </p>
          <p>Note: Carriers are heterozygotes for this autosomal recessive disorder and are not at risk of developing the disorder.</p>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies may be performed using molecular or biochemical studies:</p>
          <list list-type="bullet">
            <list-item>
              <p>Testing of at-risk pregnancies using <italic toggle="yes">SLC17A5</italic> sequence analysis requires prior identification of the disease-causing mutations in the family.</p>
            </list-item>
            <list-item>
              <p>For suspected ISSD, cultured amniocytes or tissue obtained by CVS can be used for measurement of tissue free sialic acid levels.</p>
            </list-item>
            <list-item>
              <p>For suspected Salla disease, cultured amniocytes may have sialic acid levels that are inadequately elevated to reliably differentiate them from the sialic acid levels seen in normals/carriers. Therefore, uncultured tissue derived from CVS is the preferred specimen for free sialic acid measurement [<xref ref-type="bibr" rid="issd.REF.salomaki.2001.354">Salomaki et al 2001</xref>, <xref ref-type="bibr" rid="issd.REF.aula.2006.655">Aula &#x00026; Aula 2006</xref>, <xref ref-type="bibr" rid="issd.REF.gopaul.2006.155">Gopaul &#x00026; Crook 2006</xref>].</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec id="issd.Clinical_Description">
        <title>Clinical Characteristics</title>
        <sec id="issd.Natural_History">
          <title>Clinical Description</title>
          <p>The phenotypes of the allelic disorders of free sialic acid metabolism &#x02014; Salla disease, intermediate severe Salla disease, and infantile free sialic acid storage disease (ISSD) &#x02014; range from mild to severe. All are neurodegenerative disorders resulting from increased lysosomal storage of free sialic acid [<xref ref-type="bibr" rid="issd.REF.aula.2001.1">Aula &#x00026; Gahl 2001</xref>]. Onset varies from apparently unaffected in the newborn period to severely affected prenatally.</p>
          <sec id="issd.Salla_Disease">
            <title>Salla Disease</title>
            <p>Salla disease is the mildest phenotype [<xref ref-type="bibr" rid="issd.REF.varho.2002.267">Varho et al 2002</xref>], characterized by a normal appearance and normal neurologic findings at birth followed by slowly progressive neurologic deterioration resulting in mild-to-moderate psychomotor retardation [<xref ref-type="bibr" rid="issd.REF.renlund.1983.57">Renlund et al 1983</xref>, <xref ref-type="bibr" rid="issd.REF.alajoki.2004.832">Alajoki et al 2004</xref>]. Muscular hypotonia is often first recognized at approximately age six months. One third of affected children learn to walk. Speech can be limited to single words but understanding of speech is good. Slow developmental progress often continues until the third decade, after which regression can occur.</p>
            <p>Some individuals with Salla disease present later in life with spasticity, athetosis, and epileptic seizures, becoming nonambulatory and nonverbal. Affected individuals are characterized as good-humored and sociable [<xref ref-type="bibr" rid="issd.REF.varho.2002.267">Varho et al 2002</xref>].</p>
            <p>Abnormal myelination of the basal ganglia and hypoplasia of the corpus callosum are constant and early findings. MRI reveals these predominant white matter changes [<xref ref-type="bibr" rid="issd.REF.sonninen.1999.433">Sonninen et al 1999</xref>]. Cerebellar white matter changes are also present and can explain the ataxia [<xref ref-type="bibr" rid="issd.REF.linnankivi.2003.107">Linnankivi et al 2003</xref>, <xref ref-type="bibr" rid="issd.REF.biancheri.2004.587">Biancheri et al 2004</xref>].</p>
            <p>In addition to the central dysmyelination, a peripheral dysmyelination with the clinical picture of a polyneuropathy occurs with variable neurologic presentations [<xref ref-type="bibr" rid="issd.REF.varho.2000.99">Varho et al 2000</xref>, <xref ref-type="bibr" rid="issd.REF.varho.2002.267">Varho et al 2002</xref>].</p>
            <p>Affected individuals do not have organomegaly, skeletal dysostosis, or abnormal eye findings. In a single individual, growth hormone and gonadotropin deficiencies were observed [<xref ref-type="bibr" rid="issd.REF.grosso.2001.775">Grosso et al 2001</xref>].</p>
            <p>Life expectancy appears to be shortened, although affected individuals up to age 72 years have been observed.</p>
            <p><bold>Intermediate severe Salla disease.</bold> Since the advent of molecular studies, phenotypes with a severity between those of Salla disease and ISSD [<xref ref-type="bibr" rid="issd.REF.aula.2001.1">Aula &#x00026; Gahl 2001</xref>] have been attributed to compound heterozygosity for the Salla disease common mutation <xref ref-type="table" rid="issd.T.slc17a5_allelic_variants_discusse">p.Arg39Cys</xref> and another <italic toggle="yes">SLC17A5</italic> mutation [<xref ref-type="bibr" rid="issd.REF.kleta.2003.28">Kleta et al 2003</xref>]. Thus the term "intermediate severe Salla disease" was proposed [<xref ref-type="bibr" rid="issd.REF.aula.2000.832">Aula et al 2000</xref>].</p>
          </sec>
          <sec id="issd.Infantile_Free_Sialic_Acid_Storage">
            <title>Infantile Free Sialic Acid Storage Disease (ISSD)</title>
            <p>ISSD, the most severe phenotype, is characterized by severe developmental delays, coarse facial features, hepatosplenomegaly, and cardiomegaly. ISSD can present prenatally and in the neonatal period with nonimmune hydrops fetalis [<xref ref-type="bibr" rid="issd.REF.lemyre.1999.385">Lemyre et al 1999</xref>, <xref ref-type="bibr" rid="issd.REF.stone.1999.409">Stone &#x00026; Sidransky 1999</xref>, <xref ref-type="bibr" rid="issd.REF.froissart.2005.829">Froissart et al 2005</xref>]. Some affected infants are born prematurely. Other affected infants appear normal at birth but deteriorate and lose milestones during infancy [<xref ref-type="bibr" rid="issd.REF.kleta.2003.28">Kleta et al 2003</xref>, <xref ref-type="bibr" rid="issd.REF.kleta.2004.137">Kleta et al 2004</xref>]. Seizures are common.</p>
            <p>Some infants with ISSD develop proteinuria and nephrotic syndrome [<xref ref-type="bibr" rid="issd.REF.lemyre.1999.385">Lemyre et al 1999</xref>, <xref ref-type="bibr" rid="issd.REF.ishiwari.2004.656">Ishiwari et al 2004</xref>].</p>
            <p>Skeletal changes may include irregular metaphyses, diffuse hypomineralization, club feet, short femurs, enlarged metaphyses, fractures, hip dysplasia, anterior beaking of the dorsal vertebrae, and hypoplasia of the distal phalanges [<xref ref-type="bibr" rid="issd.REF.froissart.2005.829">Froissart et al 2005</xref>].</p>
            <p>Death usually occurs in early childhood, typically from respiratory infections.</p>
          </sec>
        </sec>
        <sec id="issd.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Correlations between the type of <italic toggle="yes">SLC17A5</italic> mutation and the severity of the lysosomal free sialic acid storage disease have been identified [<xref ref-type="bibr" rid="issd.REF.aula.2000.832">Aula et al 2000</xref>, <xref ref-type="bibr" rid="issd.REF.varho.2000.99">Varho et al 2000</xref>, <xref ref-type="bibr" rid="issd.REF.kleta.2003.28">Kleta et al 2003</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>Homozygosity for the missense mutation <xref ref-type="table" rid="issd.T.slc17a5_allelic_variants_discusse">p.Arg39Cys</xref>, a single Finnish founder mutation, leads to Salla disease, with its slow clinical course of neurologic deterioration.</p>
            </list-item>
            <list-item>
              <p>Compound heterozygosity for the p.Arg39Cys mutation and another <italic toggle="yes">SLC17A5</italic> mutation leads to intermediate severe Salla disease, as does homozygosity for the <xref ref-type="table" rid="issd.T.slc17a5_allelic_variants_discusse">p.Lys136Glu</xref> mutation [<xref ref-type="bibr" rid="issd.REF.biancheri.2005.195">Biancheri et al 2005</xref>].</p>
            </list-item>
            <list-item>
              <p>Compound heterozygosity for mutations other than p.Arg39Cys leads to the severe phenotype of ISSD, with early onset and multisystemic involvement.</p>
            </list-item>
          </list>
          <p>Variable expression has been observed among affected family members [<xref ref-type="bibr" rid="issd.REF.landau.2004.167">Landau et al 2004</xref>].</p>
        </sec>
        <sec id="issd.Penetrance">
          <title>Penetrance</title>
          <p>Free sialic acid storage disorders seem to be fully penetrant. However, <xref ref-type="bibr" rid="issd.REF.mochel.2009.753">Mochel et al [2009]</xref> reported a case of two individuals with homozygous <xref ref-type="table" rid="issd.T.slc17a5_allelic_variants_discusse">p.Lys136Glu</xref> mutations, no detectable urinary sialic acid abnormality, and elevated CSF free sialic acid suggesting that penetrance based on urinary studies alone may be incomplete. </p>
        </sec>
        <sec id="issd.Nomenclature">
          <title>Nomenclature</title>
          <p>Free sialic acid storage disorders have been and continue to be labeled with different terms, mainly because of the different names used to denote N-acetylneuraminic acid. Although no consensus exists, the terms Salla disease, intermediate severe Salla disease, and ISSD are the most widely accepted; NANA disease is falling into disuse. Further confusion results from the fact that ISSD and Salla disease are often diagnosed without firm molecular proof, and show variable clinical expression in affected individuals.</p>
        </sec>
        <sec id="issd.Prevalence">
          <title>Prevalence</title>
          <p>Salla disease has been reported in approximately 150 individuals, mainly from Finland and Sweden [<xref ref-type="bibr" rid="issd.REF.aula.2000.832">Aula et al 2000</xref>, <xref ref-type="bibr" rid="issd.REF.erikson.2002.1324">Erikson et al 2002</xref>]. Individuals with molecularly proven Salla disease have been identified outside of Finland and Sweden [<xref ref-type="bibr" rid="issd.REF.martin.2003.23">Martin et al 2003</xref>]. The prevalence of the <italic toggle="yes">SLC17A5</italic> mutation <xref ref-type="table" rid="issd.T.slc17a5_allelic_variants_discusse">p.Arg39Cys</xref> is high in the founder region of northeastern Finland, where the carrier frequency is in the range of 1:100 [<xref ref-type="bibr" rid="issd.REF.aula.2000.832">Aula et al 2000</xref>]. Ninety-five percent of individuals of Finnish heritage with Salla disease have the p.Arg39Cys mutation. The prevalence of other <italic toggle="yes">SLC17A5</italic> mutations appears to be independent of the geographic origin or ethnicity of affected individuals; their presence has been documented in more than 30 individuals from several countries throughout the world [<xref ref-type="bibr" rid="issd.REF.lemyre.1999.385">Lemyre et al 1999</xref>, <xref ref-type="bibr" rid="issd.REF.aula.2000.832">Aula et al 2000</xref>, <xref ref-type="bibr" rid="issd.REF.kleta.2003.28">Kleta et al 2003</xref>, <xref ref-type="bibr" rid="issd.REF.martin.2003.23">Martin et al 2003</xref>, <xref ref-type="bibr" rid="issd.REF.sonderbychristensen.2003.1357">Sonderby Christensen et al 2003</xref>, <xref ref-type="bibr" rid="issd.REF.kleta.2004.137">Kleta et al 2004</xref>].</p>
        </sec>
      </sec>
      <sec id="issd.Genetically_Related_Allelic_Disorde">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>Salla disease, ISSD, and intermediate severe Salla disease are the only phenotypes known to be associated with mutations in <italic toggle="yes">SLC17A5</italic>.</p>
      </sec>
      <sec id="issd.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <sec id="issd.Increased_Urinary_and_Cellular_Free">
          <title>Increased Urinary and Cellular Free Sialic Acid</title>
          <p><related-object link-type="booklink" source-id="gene" document-id="sft" document-type="chapter"><bold>Sialuria</bold></related-object>. The clinical course of sialuria involves developmental delay and hepatomegaly but does not include severe neurologic involvement or early death [<xref ref-type="bibr" rid="issd.REF.seppala.1999.1563">Seppala et al 1999</xref>, <xref ref-type="bibr" rid="issd.REF.enns.2001.328">Enns et al 2001</xref>, <xref ref-type="bibr" rid="issd.REF.leroy.2001.1419">Leroy et al 2001</xref>]. In sialuria, elevation of free sialic acid occurs in the cytoplasm rather than in the lysosome. The only disorders in which significantly elevated urinary and cellular free sialic acid are known to occur are sialuria and the free sialic acid storage disorders (Salla disease and ISSD).</p>
          <p>Based on clinical suspicion and the finding of elevated free sialic acid in the urine, one of two steps is taken to distinguish these conditions: </p>
          <list list-type="bullet">
            <list-item>
              <p>The cellular (cytoplasmic versus lysosomal) localization of free sialic acid can be documented; a predominantly lysosomal localization indicates Salla disease or ISSD.</p>
            </list-item>
          </list>
          <p>Molecular studies of <italic toggle="yes">SLC17A5</italic> (for Salla disease and ISSD) or <italic toggle="yes">GNE</italic> (for sialuria) can be performed. Of interest, all of the published sialuria-causing mutations in <italic toggle="yes">GNE</italic> have been localized to a small region of the gene (p.Arg263 &#x02013; p.Arg266) thought to be important for allosteric feedback regulation [<xref ref-type="bibr" rid="issd.REF.ferreira.1999.131">Ferreira et al 1999</xref>]. See <related-object link-type="booklink" source-id="gene" document-id="sft" document-type="chapter">Sialuria</related-object>, Molecular Genetics.</p>
          <p>Other causes of mild elevation in urinary free sialic acid may exist.</p>
          <p><bold>Sialidosis and galactosialidosis.</bold> If sialic acid bound to glycoproteins or glycolipids is stored, disorders such as sialidosis caused by sialidase (neuraminidase) deficiency and galactosialidosis caused by combined sialidase and galactosidase deficiency should be considered. These enzyme deficiencies involve lysosomal storage of sialic acid-containing glycoconjugates [<xref ref-type="bibr" rid="issd.REF.gahl.1996.1">Gahl et al 1996</xref>]. Both of these disorders have features typical of lysosomal storage diseases but vary widely in their manifestations.</p>
        </sec>
        <sec id="issd.Clinical_Findings">
          <title>Clinical Findings</title>
          <p>Several lysosomal storage disorders display the clinical manifestation of coarse facial features and developmental delays. Other causes of nonimmune hydrops fetalis include: alpha-iduronidase deficiency (<related-object link-type="booklink" source-id="gene" document-id="mps1" document-type="chapter">MPS1</related-object>), glycosylceramidase deficiency (<related-object link-type="booklink" source-id="gene" document-id="gaucher" document-type="chapter">Gaucher disease</related-object>), beta-glucuronidase deficiency, I-cell disease, beta-glucosidase deficiency, <related-object link-type="booklink" source-id="gene" document-id="npab" document-type="chapter">acid sphingomyelinase deficiency</related-object>, acid lipase deficiency, galactosylcerabrosidase deficiency (<related-object link-type="booklink" source-id="gene" document-id="krabbe" document-type="chapter">Krabbe disease</related-object>), sialidase deficiency, and galactosialidosis.</p>
        </sec>
      </sec>
      <sec id="issd.Management">
        <title>Management</title>
        <sec id="issd.Evaluations_Following_Initial_Diagn">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with a free sialic acid storage disorder, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Neurologic and developmental evaluations to establish a baseline for educational and rehabilitation interventions</p>
            </list-item>
            <list-item>
              <p>MRINote: MRI may reveal classic brain findings, but correlations between such findings and disease severity have not been established.</p>
            </list-item>
            <list-item>
              <p>Biochemical genetics or neurogenetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="issd.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>The medical and psychosocial management of individuals with free sialic acid storage disorders is symptomatic and supportive.</p>
          <p>Management focuses on rehabilitation to optimize mobility and communication.</p>
          <p>Programs to foster normal development and assure adequate nutrition should be implemented.</p>
          <p>Treatment of seizures follows standard management principles.</p>
        </sec>
        <sec id="issd.Surveillance">
          <title>Surveillance</title>
          <p>Regular evaluation by a rehabilitation specialist may identify potentially helpful interventions.</p>
        </sec>
        <sec id="issd.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>No routine testing is recommended because adult presentations are unusual and no early interventions are available.</p>
          <p>See <xref ref-type="sec" rid="issd.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="issd.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="issd.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="issd.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>The free sialic acid storage disorders are inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="issd.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected child are obligate heterozygotes and thus carry one mutant allele. </p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Once an at-risk sib is known to be unaffected, the chance of his/her being a carrier is 2/3.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes are asymptomatic.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Because of the severity of the disease, affected individuals are unlikely to reproduce.</p>
          <p><bold>Other family members of a proband.</bold> Each sib of the proband's parents is at a 50% risk of being a carrier.</p>
        </sec>
        <sec id="issd.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>Carrier testing for at-risk family members is possible if the disease-causing mutations have been identified in the family.</p>
        </sec>
        <sec id="issd.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy. </p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are carriers or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals. </p>
        </sec>
        <sec id="issd.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p><bold>Biochemical genetic testing.</bold> Prenatal testing for pregnancies at increased risk is possible by measuring free sialic acid either in chorionic villus biopsy specimens (obtained by chorionic villus sampling at ~10-12 weeks' gestation) or in amniocytes (obtained by amniocentesis usually performed at ~15-18 weeks' gestation) [<xref ref-type="bibr" rid="issd.REF.salomaki.2001.354">Salomaki et al 2001</xref>]. </p>
          <p>Note: Gestational age is expressed as menstrual weeks calculated either from the first day of the last normal menstrual period or by ultrasound measurements.</p>
          <p><bold>Molecular genetic testing.</bold> If the disease-causing mutations have been identified in a family member, prenatal testing for pregnancies at increased risk is possible either through a clinical laboratory or a laboratory offering custom prenatal testing. </p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the disease-causing mutations have been identified. </p>
        </sec>
      </sec>
      <sec id="issd.Resources">
        <title>Resources</title>
      </sec>
      <sec id="issd.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="issd.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>Mutations in <italic toggle="yes">SLC17A5</italic> lead to defective sialin and elevated intralysosomal free sialic acid. How elevated intralysosomal free sialic acid causes pathology is not understood. Expression of sialin in the brain may explain part of the neurologic sequelae of Salla disease/ISSD [<xref ref-type="bibr" rid="issd.REF.aula.2004.251">Aula et al 2004</xref>].</p>
          <p><bold>Gene structure.</bold>
<italic toggle="yes">SLC17A5</italic> consists of 11 exons, all of which are coding exons. Northern blot analysis shows major transcripts of 3.5 kb and 4.5 kb [<xref ref-type="bibr" rid="issd.REF.verheijen.1999.462">Verheijen et al 1999</xref>]. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="issd" object-id="issd.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Benign allelic variants</bold>. One known benign variant in the coding region is p.Ala43Thr.</p>
          <p><bold>Pathogenic allelic variants.</bold> Different missense, nonsense, and splice site mutations, insertions, and deletions have been recognized as causing lysosomal free sialic acid storage disorders [<xref ref-type="bibr" rid="issd.REF.verheijen.1999.462">Verheijen et al 1999</xref>, <xref ref-type="bibr" rid="issd.REF.aula.2000.832">Aula et al 2000</xref>, <xref ref-type="bibr" rid="issd.REF.varho.2002.267">Varho et al 2002</xref>, <xref ref-type="bibr" rid="issd.REF.kleta.2003.28">Kleta et al 2003</xref>, <xref ref-type="bibr" rid="issd.REF.martin.2003.23">Martin et al 2003</xref>]. The p.Arg39Cys mutation is highly prevalent among affected individuals of Finnish heritage (see <xref ref-type="sec" rid="issd.Prevalence">Prevalence</xref>).</p>
          <table-wrap id="issd.T.slc17a5_allelic_variants_discusse" position="anchor" orientation="portrait">
            <label>Table 2.</label>
            <caption>
              <p><italic toggle="yes">SLC17A5</italic> Allelic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
            </caption>
            <table>
              <tbody>
                <tr>
                  <th id="hd_b_issd.T.slc17a5_allelic_variants_discusse_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Class of Variant Allele</th>
                  <th id="hd_b_issd.T.slc17a5_allelic_variants_discusse_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">DNA Nucleotide Change </th>
                  <th id="hd_b_issd.T.slc17a5_allelic_variants_discusse_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Protein Amino Acid Change</th>
                  <th id="hd_b_issd.T.slc17a5_allelic_variants_discusse_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Reference Sequences </th>
                </tr>
                <tr>
                  <td headers="hd_b_issd.T.slc17a5_allelic_variants_discusse_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">
                    <bold>Benign</bold>
                  </td>
                  <td headers="hd_b_issd.T.slc17a5_allelic_variants_discusse_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.127G&#x0003e;A</td>
                  <td headers="hd_b_issd.T.slc17a5_allelic_variants_discusse_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Ala43Thr</td>
                  <td headers="hd_b_issd.T.slc17a5_allelic_variants_discusse_1_1_1_4" align="left" valign="middle" rowspan="3" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_012434.4">NM_012434.4</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&#x00026;id=6912666">NP_036566.1</ext-link>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_b_issd.T.slc17a5_allelic_variants_discusse_1_1_1_1" align="left" valign="middle" rowspan="2" colspan="1">
                    <bold>Pathogenic</bold>
                  </td>
                  <td headers="hd_b_issd.T.slc17a5_allelic_variants_discusse_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.115C&#x0003e;T</td>
                  <td headers="hd_b_issd.T.slc17a5_allelic_variants_discusse_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Arg39Cys</td>
                </tr>
                <tr>
                  <td headers="hd_b_issd.T.slc17a5_allelic_variants_discusse_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.406A&#x0003e;G</td>
                  <td headers="hd_b_issd.T.slc17a5_allelic_variants_discusse_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Lys136Glu</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="issd.TF.3">
                <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants. </p>
              </fn>
              <fn id="issd.TF.3.1">
                <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature. </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Normal gene product.</bold> The gene product of <italic toggle="yes">SLC17A5</italic>, sialin, is a 495-amino acid lysosomal membrane transport protein. Sialin has 42% sequence identity with transport proteins found in rat and mouse. Sialin is an integral lysosomal membrane transporter that exports free sialic acid from lysosomes [<xref ref-type="bibr" rid="issd.REF.renlund.1986.759">Renlund et al 1986</xref>, <xref ref-type="bibr" rid="issd.REF.mancini.1991.1329">Mancini et al 1991</xref>]. Deficient or defective sialin results in excessive lysosomal storage of the free sialic acid produced by lysosomal degradation of glycoproteins and glycolipids.</p>
          <p><bold>Abnormal gene product.</bold> It is presumed that most <italic toggle="yes">SLC17A5</italic> mutations result in defective or absent sialin. However, for two known mutations in <italic toggle="yes">SLC17A5</italic>, sialin is misrouted and fails to incorporate into the lysosomal membrane, which may be thought of as the functional equivalent of absent sialin [<xref ref-type="bibr" rid="issd.REF.aula.2002.99">Aula et al 2002</xref>, <xref ref-type="bibr" rid="issd.REF.wreden.2005.1408">Wreden et al 2005</xref>]. </p>
        </sec>
      </sec>
      <sec id="issd.References">
        <title>References</title>
        <sec id="issd.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="issd.Literature_Cited.reflist0">
            <ref id="issd.REF.aula.2006.655">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Aula</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aula</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Prenatal diagnosis of free sialic acid storage disorders (SASD).</article-title>
                <source>Prenat Diagn</source>
                <year>2006</year>
                <volume>26</volume>
                <fpage>655</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16715535</pub-id>
              </element-citation>
            </ref>
            <ref id="issd.REF.aula.2002.99">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Aula</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jalanko</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aula</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peltonen</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>Unraveling the molecular pathogenesis of free sialic acid storage disorders: altered targeting of mutant sialin.</article-title>
                <source>Mol Genet Metab.</source>
                <year>2002</year>
                <volume>77</volume>
                <fpage>99</fpage>
                <lpage>107</lpage>
                <pub-id pub-id-type="pmid">12359136</pub-id>
              </element-citation>
            </ref>
            <ref id="issd.REF.aula.2004.251">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Aula</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kopra</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jalanko</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peltonen</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>Sialin expression in the CNS implicates extralysosomal function in neurons.</article-title>
                <source>Neurobiol Dis</source>
                <year>2004</year>
                <volume>15</volume>
                <fpage>251</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">15006695</pub-id>
              </element-citation>
            </ref>
            <ref id="issd.REF.aula.2000.832">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Aula</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salomaki</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timonen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verheijen</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mancini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mansson</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aula</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peltonen</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>The spectrum of SLC17A5-gene mutations resulting in free sialic acid-storage diseases indicates some genotype-phenotype correlation.</article-title>
                <source>Am J Hum Genet</source>
                <year>2000</year>
                <volume>67</volume>
                <fpage>832</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">10947946</pub-id>
              </element-citation>
            </ref>
            <ref id="issd.REF.aula.2001.1">
              <mixed-citation publication-type="book">Aula P, Gahl WA. Disorders of free sialic acid storage. In: Scriver CR, Beaudet AL, Valle D, Sly WS, eds. <italic toggle="yes">The Metabolic &#x00026; Molecular Bases of Inherited Disease</italic>. 8 ed. New York, NY: McGraw-Hill; 2001:5109-20.</mixed-citation>
            </ref>
            <ref id="issd.REF.biancheri.2004.587">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Biancheri</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mancini</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minetti</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Cerebellar white matter involvement in Salla disease.</article-title>
                <source>Neuroradiology</source>
                <year>2004</year>
                <volume>46</volume>
                <fpage>587</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15179531</pub-id>
              </element-citation>
            </ref>
            <ref id="issd.REF.biancheri.2005.195">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Biancheri</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verbeek</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schot</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corsolini</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Assereto</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mancini</surname>
                    <given-names>GMS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verheijen</surname>
                    <given-names>FW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minetti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filocamo</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Homozygosity for the p.K136E mutation in the SLC15A5 gene as cause of an Italian severe Salla disease.</article-title>
                <source>Neurogenetics</source>
                <year>2005</year>
                <volume>6</volume>
                <fpage>195</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16170568</pub-id>
              </element-citation>
            </ref>
            <ref id="issd.REF.enns.2001.328">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Enns</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seppala</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Musci</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weisiger</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrell</surname>
                    <given-names>LD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wenger</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gahl</surname>
                    <given-names>WA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Packman</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Clinical course and biochemistry of sialuria.</article-title>
                <source>J Inherit Metab Dis</source>
                <year>2001</year>
                <volume>24</volume>
                <fpage>328</fpage>
                <lpage>36</lpage>
                <pub-id pub-id-type="pmid">11486897</pub-id>
              </element-citation>
            </ref>
            <ref id="issd.REF.erikson.2002.1324">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Erikson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aula</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aula</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mansson</surname>
                    <given-names>JE</given-names>
                  </name>
                </person-group>
                <article-title>Free sialic acid storage (Salla) disease in Sweden.</article-title>
                <source>Acta Paediatr</source>
                <year>2002</year>
                <volume>91</volume>
                <fpage>1324</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12578289</pub-id>
              </element-citation>
            </ref>
            <ref id="issd.REF.ferreira.1999.131">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ferreira</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seppala</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinto</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huizing</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martins</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Braga</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gomes</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krasnewich</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sa Miranda</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gahl</surname>
                    <given-names>WA</given-names>
                  </name>
                </person-group>
                <article-title>Sialuria in a Portuguese girl: clinical, biochemical, and molecular characteristics.</article-title>
                <source>Mol Genet Metab.</source>
                <year>1999</year>
                <volume>67</volume>
                <fpage>131</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">10356312</pub-id>
              </element-citation>
            </ref>
            <ref id="issd.REF.froissart.2005.829">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Froissart</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheillan</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouvier</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tourret</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonnet</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piraud</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maire</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <article-title>Clinical, morphological and molecular aspects of sialic acid storage disease manifesting in utero.</article-title>
                <source>J Med Genet</source>
                <year>2005</year>
                <volume>42</volume>
                <fpage>829</fpage>
                <lpage>36</lpage>
                <pub-id pub-id-type="pmid">15805149</pub-id>
              </element-citation>
            </ref>
            <ref id="issd.REF.gahl.1996.1">
              <mixed-citation publication-type="book">Gahl WA, Krasnewich DM, Williams JC. Sialidoses. In: Vinken PJ, Bruyn GW, eds. <italic toggle="yes">Handbook of Clinical Neurology.</italic> Vol 66, chapter 18. Amsterdam, Netherlands: Elsevier; 1996:353-75.</mixed-citation>
            </ref>
            <ref id="issd.REF.gopaul.2006.155">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gopaul</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crook</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <article-title>The inborn errors of sialic acid metabolism and their laboratory investigation.</article-title>
                <source>Clin Lab</source>
                <year>2006</year>
                <volume>52</volume>
                <fpage>155</fpage>
                <lpage>69</lpage>
                <pub-id pub-id-type="pmid">16584062</pub-id>
              </element-citation>
            </ref>
            <ref id="issd.REF.grosso.2001.775">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Grosso</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berardi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farnetani</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Margollicci</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mancini</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgese</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balestri</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Multiple neuroendocrine disorder in Salla disease.</article-title>
                <source>J Child Neurol</source>
                <year>2001</year>
                <volume>16</volume>
                <fpage>775</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">11669356</pub-id>
              </element-citation>
            </ref>
            <ref id="issd.REF.helipwooley.2007.1">
              <mixed-citation publication-type="book">Helip-Wooley A, Kleta R, Gahl WA. Lysosomal free sialic acid storage disorders: salla disease and ISSD. In: Barranger JA, Cabrera-Salazar MA, eds. <italic toggle="yes">Lysosomal Storage Disorders.</italic> New York, NY: Springer; 2007:499-511.</mixed-citation>
            </ref>
            <ref id="issd.REF.alajoki.2004.832">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Alajoki</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Varho</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Posti</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aula</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korhonen</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Neurocognitive profiles in Salla disease.</article-title>
                <source>Dev Med Child Neurol</source>
                <year>2004</year>
                <volume>46</volume>
                <fpage>832</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">15581157</pub-id>
              </element-citation>
            </ref>
            <ref id="issd.REF.ishiwari.2004.656">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ishiwari</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kotani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pumbo</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ueno</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukushige</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kanzaki</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imada</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Itoh</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akioka</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tajima</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakuraba</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Clinical, biochemical, and cytochemical studies on a Japanese Salla disease case associated with a renal disorder.</article-title>
                <source>J Hum Genet</source>
                <year>2004</year>
                <volume>49</volume>
                <fpage>656</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">15635485</pub-id>
              </element-citation>
            </ref>
            <ref id="issd.REF.kleta.2003.28">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kleta</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aughton</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rivkin</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huizing</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strovel</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anikster</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orvisky</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Natowicz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krasnewich</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gahl</surname>
                    <given-names>WA</given-names>
                  </name>
                </person-group>
                <article-title>Biochemical and molecular analyses of infantile free sialic acid storage disease in North American children.</article-title>
                <source>Am J Med Genet</source>
                <year>2003</year>
                <volume>120A</volume>
                <fpage>28</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">12794688</pub-id>
              </element-citation>
            </ref>
            <ref id="issd.REF.kleta.2004.137">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kleta</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morse</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orvisky</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krasnewich</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alroy</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ucci</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernardini</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wenger</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gahl</surname>
                    <given-names>WA</given-names>
                  </name>
                </person-group>
                <article-title>Clinical, biochemical, and molecular diagnosis of a free sialic acid storage disease patient of moderate severity.</article-title>
                <source>Mol Genet Metab</source>
                <year>2004</year>
                <volume>82</volume>
                <fpage>137</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">15172001</pub-id>
              </element-citation>
            </ref>
            <ref id="issd.REF.landau.2004.167">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Landau</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shalev</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinsk</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yerushalmi</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeigler</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Birk</surname>
                    <given-names>OS</given-names>
                  </name>
                </person-group>
                <article-title>A novel mutation in the SLC17A5 gene causing both severe and mild phenotypes of free sialic acid storage disease in one inbred Bedouin kindred.</article-title>
                <source>Mol Genet Metab</source>
                <year>2004</year>
                <volume>82</volume>
                <fpage>167</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">15172005</pub-id>
              </element-citation>
            </ref>
            <ref id="issd.REF.lemyre.1999.385">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lemyre</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Russo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Melancon</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gagne</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Potier</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lambert</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Clinical spectrum of infantile free sialic acid storage disease.</article-title>
                <source>Am J Med Genet</source>
                <year>1999</year>
                <volume>82</volume>
                <fpage>385</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">10069709</pub-id>
              </element-citation>
            </ref>
            <ref id="issd.REF.leroy.2001.1419">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leroy</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seppala</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huizing</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dacremont</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Simpel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Coster</surname>
                    <given-names>RN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orvisky</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krasnewich</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gahl</surname>
                    <given-names>WA</given-names>
                  </name>
                </person-group>
                <article-title>Dominant inheritance of sialuria, an inborn error of feedback inhibition.</article-title>
                <source>Am J Hum Genet</source>
                <year>2001</year>
                <volume>68</volume>
                <fpage>1419</fpage>
                <lpage>27</lpage>
                <pub-id pub-id-type="pmid">11326336</pub-id>
              </element-citation>
            </ref>
            <ref id="issd.REF.linnankivi.2003.107">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Linnankivi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lonnqvist</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Autti</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>A case of Salla disease with involvement of the cerebellar white matter.</article-title>
                <source>Neuroradiology</source>
                <year>2003</year>
                <volume>45</volume>
                <fpage>107</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12592494</pub-id>
              </element-citation>
            </ref>
            <ref id="issd.REF.mancini.1991.1329">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mancini</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beerens</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aula</surname>
                    <given-names>PP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verheijen</surname>
                    <given-names>FW</given-names>
                  </name>
                </person-group>
                <article-title>Sialic acid storage diseases. A multiple lysosomal transport defect for acidic monosaccharides.</article-title>
                <source>J Clin Invest</source>
                <year>1991</year>
                <volume>87</volume>
                <fpage>1329</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">2010546</pub-id>
              </element-citation>
            </ref>
            <ref id="issd.REF.martin.2003.23">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slaugh</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Natowicz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearlman</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orvisky</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krasnewich</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleta</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huizing</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gahl</surname>
                    <given-names>WA</given-names>
                  </name>
                </person-group>
                <article-title>Sialic acid storage disease of the Salla phenotype in American monozygous twin female sibs.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2003</year>
                <volume>120A</volume>
                <fpage>23</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12794687</pub-id>
              </element-citation>
            </ref>
            <ref id="issd.REF.mochel.2009.753">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mochel</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barritault</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>JN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engelke</surname>
                    <given-names>UF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McNeill</surname>
                    <given-names>NH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benko</surname>
                    <given-names>WS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaneski</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adams</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsokos</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abu-Asab</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huizing</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seguin</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wevers</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ding</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verheijen</surname>
                    <given-names>FW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Free sialic acid storage disease without sialuria.</article-title>
                <source>Ann Neurol.</source>
                <year>2009</year>
                <volume>65</volume>
                <fpage>753</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">19557856</pub-id>
              </element-citation>
            </ref>
            <ref id="issd.REF.renlund.1983.57">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Renlund</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aula</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raivio</surname>
                    <given-names>KO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Autio</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sainio</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rapola</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koskela</surname>
                    <given-names>SL</given-names>
                  </name>
                </person-group>
                <article-title>Salla disease: a new lysosomal storage disorder with disturbed sialic acid metabolism.</article-title>
                <source>Neurology</source>
                <year>1983</year>
                <volume>33</volume>
                <fpage>57</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">6681560</pub-id>
              </element-citation>
            </ref>
            <ref id="issd.REF.renlund.1986.759">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Renlund</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tietze</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gahl</surname>
                    <given-names>WA</given-names>
                  </name>
                </person-group>
                <article-title>Defective sialic acid egress from isolated fibroblast lysosomes of patients with Salla disease.</article-title>
                <source>Science</source>
                <year>1986</year>
                <volume>232</volume>
                <fpage>759</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">3961501</pub-id>
              </element-citation>
            </ref>
            <ref id="issd.REF.salomaki.2001.354">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Salomaki</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aula</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Juvonen</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Renlund</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aula</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Prenatal detection of free sialic acid storage disease: genetic and biochemical studies in nine families.</article-title>
                <source>Prenat Diagn</source>
                <year>2001</year>
                <volume>21</volume>
                <fpage>354</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11360275</pub-id>
              </element-citation>
            </ref>
            <ref id="issd.REF.seppala.1999.1563">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Seppala</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehto</surname>
                    <given-names>VP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gahl</surname>
                    <given-names>WA</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in the human UDP-N-acetylglucosamine 2-epimerase gene define the disease sialuria and the allosteric site of the enzyme.</article-title>
                <source>Am J Hum Genet</source>
                <year>1999</year>
                <volume>64</volume>
                <fpage>1563</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10330343</pub-id>
              </element-citation>
            </ref>
            <ref id="issd.REF.sonderbychristensen.2003.1357">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sonderby Christensen</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaad</surname>
                    <given-names>PH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ostergaard</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <article-title>Two cases of Salla disease in Danish children.</article-title>
                <source>Acta Paediatr</source>
                <year>2003</year>
                <volume>92</volume>
                <fpage>1357</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">14696864</pub-id>
              </element-citation>
            </ref>
            <ref id="issd.REF.sonninen.1999.433">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sonninen</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Autti</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Varho</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamalainen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raininko</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Brain involvement in Salla disease.</article-title>
                <source>AJNR Am J Neuroradiol</source>
                <year>1999</year>
                <volume>20</volume>
                <fpage>433</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">10219409</pub-id>
              </element-citation>
            </ref>
            <ref id="issd.REF.stone.1999.409">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stone</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sidransky</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>Hydrops fetalis: lysosomal storage disorders in extremis.</article-title>
                <source>Adv Pediatr</source>
                <year>1999</year>
                <volume>46</volume>
                <fpage>409</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">10645471</pub-id>
              </element-citation>
            </ref>
            <ref id="issd.REF.valianpour.2004.403">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Valianpour</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abeling</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duran</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huijmans</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kulik</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <article-title>Quantification of free sialic acid in urine by HPLC-electrospray tandem mass spectrometry: a tool for the diagnosis of sialic acid storage disease.</article-title>
                <source>Clin Chem</source>
                <year>2004</year>
                <volume>50</volume>
                <fpage>403</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">14684624</pub-id>
              </element-citation>
            </ref>
            <ref id="issd.REF.varho.2000.99">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Varho</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaaskelainen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tolonen</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sonninen</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vainionpaa</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aula</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sillanpaa</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Central and peripheral nervous system dysfunction in the clinical variation of Salla disease.</article-title>
                <source>Neurology</source>
                <year>2000</year>
                <volume>55</volume>
                <fpage>99</fpage>
                <lpage>104</lpage>
                <pub-id pub-id-type="pmid">10891913</pub-id>
              </element-citation>
            </ref>
            <ref id="issd.REF.varho.2002.267">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Varho</surname>
                    <given-names>TT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alajoki</surname>
                    <given-names>LE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Posti</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korhonen</surname>
                    <given-names>TT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Renlund</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nyman</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sillanpaa</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aula</surname>
                    <given-names>PP</given-names>
                  </name>
                </person-group>
                <article-title>Phenotypic spectrum of Salla disease, a free sialic acid storage disorder.</article-title>
                <source>Pediatr Neurol</source>
                <year>2002</year>
                <volume>26</volume>
                <fpage>267</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">11992753</pub-id>
              </element-citation>
            </ref>
            <ref id="issd.REF.verheijen.1999.462">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Verheijen</surname>
                    <given-names>FW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verbeek</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aula</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beerens</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Havelaar</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joosse</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peltonen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aula</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Galjaard</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Spek</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mancini</surname>
                    <given-names>GM</given-names>
                  </name>
                </person-group>
                <article-title>A new gene, encoding an anion transporter, is mutated in sialic acid storage diseases.</article-title>
                <source>Nat Genet</source>
                <year>1999</year>
                <volume>23</volume>
                <fpage>462</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">10581036</pub-id>
              </element-citation>
            </ref>
            <ref id="issd.REF.wreden.2005.1408">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wreden</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wlizla</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reimer</surname>
                    <given-names>RJ</given-names>
                  </name>
                </person-group>
                <article-title>Varied mechanisms underlie the free sialic acid storage disorders.</article-title>
                <source>J Biol Chem</source>
                <year>2005</year>
                <volume>280</volume>
                <fpage>1408</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">15516337</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="issd.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="issd.Suggested_Reading.reflist0">
            <ref id="issd.REF.aula.2014.1">
              <mixed-citation publication-type="book">Aula P, Gahl WA. Disorders of free sialic acid storage. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G, eds. <italic toggle="yes">The Online Metabolic and Molecular Bases of Inherited Disease (OMMBID).</italic> 2015. New York, NY: McGraw-Hill. Chap 200.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="issd.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="issd.Author_Notes">
          <title>Author Notes</title>
          <p>David Adams, MD, PhD is a pediatrician, medical geneticist, and biochemical geneticist who performs clinical and basic research into rare diseases at the National Institutes of Health.</p>
          <p>William A Gahl, MD, PhD is a pediatrician, medical geneticist, and biochemical geneticist who performs clinical and basic research into rare diseases at the National Institutes of Health.</p>
        </sec>
        <sec id="issd.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>6 June 2013 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>3 July 2008 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>4 October 2005 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>13 June 2003 (ca) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>28 February 2003 (wg) Original submission</p>
            </list-item>
          </list>
          <p>Pursuant to 17 USC Section 105 of the United States Copyright Act, the <italic toggle="yes">GeneReview</italic> "Free Sialic Acid Storage Disorders" is in the public domain in the United States of America.</p>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
